genetherapy-analytical.com Open in urlscan Pro
5.134.13.35  Public Scan

Form analysis
1 forms found in the DOM

GET https://genetherapy-analytical.com/

<form role="search" method="get" id="searchform" class="searchform" action="https://genetherapy-analytical.com/">
  <div>
    <label class="screen-reader-text" for="s"> Search</label>
    <input type="text" value="" name="s" id="s" placeholder="">
    <input type="submit" id="searchsubmit" value="Search">
  </div>
</form>

Text Content

Skip to content


NOVEMBER 28 - DECEMBER 1, 2022
BOSTON, MA

Limited passes now remain! Register Here

Get Approval from Your Boss!
Menu

 * Home
 * About
   * About Event
   * About the Gene Therapy Event Series
   * Business Case to Attend
   * Venue
   * Content Library
 * What’s On
   * Full Event Guide
   * Speakers
   * Agenda at a Glance
   * Pre-Conference Workshop Day
   * Post-Conference Focus Day: Non-AAV Vectors
 * Partnership
   * Partnership Opportunities
   * Partnership Prospectus
   * Creative Options
   * Partners
   * Media Partners
 * Take Part
   * Pricing & Registration
   * Contact Us




JUST SOME OF THE COMPANIES ATTENDING:




EVENT GUIDE
REGISTER
ABOUT


DEVELOP, VALIDATE & IMPLEMENT CELL-BASED & BIOPHYSICAL ANALYTICAL METHODS TO
GUARANTEE SAFE, HIGH QUALITY, CONSISTENT & EFFICACIOUS GENE THERAPY PRODUCTS AT
SCALE

The past twelve months have culminated in an unprecedented level of excitement,
investment, and clinical progress within the gene therapy field. As the field
strives to strike a delicate balance between safety and efficacy, in the context
of increased regulatory scrutiny and safety challenges, attending the 4th Annual
Gene Therapy Analytical Development as an analytical scientist has never been so
important.

This year’s summit returns in-person to Boston to reunite 300+ analytical
experts in innovative biotech, pharma and academia to continue to develop
resilient, long-lasting and robust analytical tools to enhance the safety,
quality and efficacy of gene therapy products.  

Whether you are focusing on specific characterization methods, enhancing your
genome sequencing, advancing your understanding of full and partial particles,
or advancing your early-stage bioassays, with 4 tracks, 8 pre-conference
workshops and a post-conference focus day, the 4th Gene Therapy Analytical
Development Summit will encompass all aspects of analytical development, giving
you the chance to address and overcome challenges.

If you work in quality control, quality assurance, or process development -
we’ve listened and we’ve answered. This year’s agenda includes a novel track
designed for quality control and process development groups working in gene
therapy. Talks include enhancing the knowledge transfer between departments,
bridging between analytical methods with regards to QC/PD, and enhancing
in-process development support.

Whether you're working with AAV, non-viral vectors or lentiviral vectors, this
is your opportunity to enhance your existing analytical methods and explore
innovative new tools to support safe and effective gene therapy development.




4 DEDICATED NEW TRACKS OF CONTENT THIS YEAR:


BIOASSAYS






DISCOVER THE LATEST UPDATES IN POTENCY ASSAY STRATEGIES, PLATFORM ASSAY
DEVELOPMENT & DEVELOPING BIOASSAYS FOR DOWNSTREAM BIOLOGICAL EFFECTS






QUALITY & PROCESS DEVELOPMENT





DEEP DIVE INTO ENHANCING KNOWLEDGE TRANSFER BETWEEN AD, QC & PD TEAMS &
OPTIMIZING PROCESS DEVELOPMENT AND MANUFACTURING PROCESSES





PRE-CLINICAL TRACK






FURTHER YOUR UNDERSTANDING OF YOUR FULL, EMPTY, & PARTIAL PARTICLES BY ENHANCING
YOUR CHARACTERIZATION METHODS







MOLECULAR BIOLOGY





EXPLORE NEXT-GENERATION SEQUENCING TECHNIQUES, ADVANCEMENTS IN TITRE METRICS &
EMERGING CHARACTERIZATION TECHNOLOGIES







WORLD-CLASS SPEAKING FACULTY INCLUDES:

CONNIE TSAI

Associate Director, Analytical Development

Novartis Gene Therapies



DWAYNE NEAL

Senior Director, Analytical Sciences & Technology

AVROBIO



JARROD DEAN

Associate Director, NGS Leader, Genomics Medicine Unit CMC

Sanofi



SUSAN SLEEP

Director, Assay Development

AGTC



ZORAN SOSIC

Associate Director of Gene Therapy Analytical Chemistry

Biogen






BRING YOUR TEAM!

10% discount - 3+ delegates
15% discount - 4+ delegates
20% discount - 5 or more delegates

REGISTER


OTHER EVENTS IN THE GENE THERAPY SERIES

www.next-gen-genetherapy-vectors.com



www.genetherapy-ophthalmology.com



www.genetherapy-neurological.com



www.genetherapy-europe.com



www.genetherapy-analytical.com



www.next-gen-genetherapy-vectors.com



www.genetherapy-ophthalmology.com



www.genetherapy-neurological.com



www.genetherapy-europe.com



www.genetherapy-analytical.com



www.next-gen-genetherapy-vectors.com



www.genetherapy-ophthalmology.com



www.genetherapy-neurological.com



View Full Event Series
BACK TO THE TOP


OUR CONTACT DETAILS

T: (+1) 617 455 4188
E: info@hansonwade.com


VENUE

Boston Park Plaza
50 Park Plaza
Boston, MA
02116, United States


ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across
industries. Our primary method for achieving this is by creating exclusive
business conferences that gather together the world's smartest thinkers and
doers.


LOCATION




SEARCH

Search


ORGANISED BY



Terms & Conditions

Privacy Policy




© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade
Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.